2018-11-14T10:58:26-06:00 2017-12-31 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE SUITE 4000 INDIANAPOLIS IN 46204 990 2017-01-01 912154267 Memorial Sloan-Kettering Cancer Center % MARK K SVENNINGSON MEMO 6462273092 1275 York Avenue New York NY 10065 MARK K SVENNINGSON SVP FINANCE 6462273092 2018-11-14 true JENNIFER D RHODERICK P00395735 3176817000 164.57.159.253 35057220183185000011 2018-11-14 P 918544D3E42C30901F4ADBB8FAA3CBA75C374DF7 42D26865FF540D3EA6F803EEB3CCA5BB79F92251 2017 2019-02-21 02:37:17Z CRAIG B THOMPSON MD 1275 York Avenue New York NY 10065 5130567288 true true 3475 X www.mskcc.org X LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION , AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. 113 103 19404 1019 -1863368 -4625287 484923582 514762000 3186824175 3683539000 67846796 189791000 198554845 110965098 3938149398 4499057098 25038386 25459000 0 0 2137534438 2319603271 139618 128216 64048940 1618534757 1839463611 3781247199 4184654098 156902199 314403000 9885345175 10632552000 4159357976 4529742000 5725987199 6102810000 X THE MISSION OF MEMORIAL SLOAN-KETTERING CANCER CENTER IS TO LEAD IN THE PREVENTION,DIAGNOSIS,TREATMENT AND CURE OF CANCER AND ASSOCIATED DISEASES THROUGH PROGRAMS OF EXCELLENCE IN RESEARCH, EDUCATION, OUTREACH AND COST-EFFECTIVE PATIENT CARE. LEADERSHIP IN PATIENT CARE: WE PLACE THE HIGHEST PRIORITY ON ADVANCING THE CARE OF CANCER PATIENTS THROUGH EARLY DETECTION, ACCURATE DIAGNOSIS, AND OPTIMAL TREATMENT. THESE THREE ELEMENTS LEAD TO THE MOST EFFECTIVE CANCER CARE POSSIBLE, WHICH IS ALSO THE MOST COST-EFFECTIVE CARE, WE STRIVE FOR EXCELLENCE IN ALL EXISTING AND EMERGING THERAPIES WITHOUT NEGLECTING THE NEED FOR ADVANCED APPROACHES IN PALLIATION. WE DELIVER THESE THERAPIES IN A CARING ENVIRONMENT THAT ENCOMPASSES PATIENTS AS WELL AS THEIR LOVED ONES. EXCELLENCE IN PATIENT CARE IS EXEMPLIFIED BY OUR MULTIDISCIPLINARY APPROACH, A CORE COMPETENCE OF OUR CENTER. WE ARE COMMITTED TO DEVELOPING OUTREACH PROGRAMS TO BRING EXCELLENCE IN CANCER CARE TO THE COMMUNITY. LEADERSHIP IN RESEARCH EXCE false false 3230695781 2979000 3586106000 PATIENT CARE: MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERTS HAVE ESTABLISHED STANDARDS OF CARE AND TREATMENT PROTOCOLS FOR EACH TYPE AND STAGE OF CANCER. OUR PHYSICIANS HAVE AN EXTRAORDINARY DEPTH AND BREADTH OF EXPERIENCE IN DIAGNOSING AND TREATING ALL FORMS OF THE DISEASE, FROM THE MOST COMMON TO THE VERY RARE. EACH YEAR, THEY TREAT MORE THAN 400 DIFFERENT SUBTYPES OF CANCER. THIS LEVEL OF SPECIALIZATION CAN HAVE AN OFTEN-DRAMATIC EFFECT ON A PATIENT'S CHANCES FOR A CURE OR CONTROL OF THEIR CANCER. WHILE WE ARE KNOWN FOR OUR ADVANCED, INNOVATIVE THERAPIES, OUR PHYSICIANS ARE EQUALLY WELL REGARDED FOR THEIR COMPASSION AND CONCERN. OUR DISEASE MANAGEMENT PROGRAM FEATURES 16 MULTIDISCIPLINARY CANCER TEAMS. PATIENTS ARE TREATED BY AS MANY DIFFERENT SPECIALISTS AS ARE NEEDED FOR THEIR PARTICULAR TYPE OF DISEASE, INCLUDING SURGEONS, MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, RADIOLOGISTS, PATHOLOGISTS, PSYCHIATRISTS, AND NURSES. OUR PATHOLOGISTS HAVE UNSURPASSED EXPERTISE IN USING ADVANCED METHODS TO ACCURATELY DIAGNOSE CANCER. BECAUSE OF THEIR SOLE FOCUS ON CANCER, OUR SURGEONS USE SURGICAL TECHNIQUES THAT PRESERVE FORM AND FUNCTION. OUR RADIATION ONCOLOGISTS ARE DEVELOPING AND PUTTING INTO CLINICAL PRACTICE LEADING-EDGE TECHNOLOGIES AND TECHNIQUES IN RADIATION THERAPY. IN ADDITION, THE CENTER OFFERS A FULL RANGE OF PROGRAMS TO HELP PATIENTS AND FAMILIES THROUGHOUT ALL PHASES OF TREATMENT, INCLUDING SUPPORT GROUPS, GENETIC COUNSELING, HELP MANAGING CANCER PAIN AND SYMPTOMS, REHABILITATION, INTEGRATIVE MEDICINE SERVICES, AND ASSISTANCE IN NAVIGATING LIFE AFTER TREATMENT. 605096727 21304000 97433000 RESEARCH: MEMORIAL SLOAN-KETTERING CANCER CENTER MAINTAINS ONE OF THE WORLD'S MOST DYNAMIC PROGRAMS OF CANCER RESEARCH. THE EXTRAORDINARY PATIENT CARE WE PROVIDE BENEFITS FROM OUR INNOVATIVE PROGRAMS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH. RESEARCH AT SLOAN-KETTERING INSTITUTE IS DEDICATED TO UNDERSTANDING THE BIOLOGY OF CANCER THROUGH PROGRAMS IN CELL BIOLOGY, GENETICS, BIOCHEMISTRY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, COMPUTATIONAL BIOLOGY, IMMUNOLOGY, AND THERAPEUTICS. INVESTIGATORS AT SLOAN-KETTERING INSTITUTE COLLABORATE WITH MEMORIAL HOSPITAL PHYSICIAN-SCIENTISTS, A PARTNERSHIP THAT HELPS SPEED IMPORTANT RESEARCH FINDINGS FROM THE LABORATORY TO THE BEDSIDE, IN A PROCESS KNOWN AS TRANSLATIONAL RESEARCH. MEMORIAL SLOAN-KETTERING CANCER CENTER ALSO ACTIVELY INITIATES AND PARTICIPATES IN CLINICAL TRIALS TO IDENTIFY MORE EFFECTIVE CANCER THERAPIES, AND OUR PHYSICIANS ARE CURRENTLY LEADING 1,072 CLINICAL TRIALS FOR PEDIATRIC AND ADULT CANCERS. THE HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM (HOPP) IS A FURTHER EFFORT TO INCREASE INSTITUTIONAL RESEARCH STRENGTH IN AREAS IMPORTANT IN CONTEMPORARY TRANSLATIONAL RESEARCH. HOPP IS DESIGNED TO MELD EVEN MORE THOROUGHLY THE CULTURES OF BASIC BIOLOGIC SCIENCE AND CLINICAL ONCOLOGY, AUGMENTING THE WORK CONDUCTED IN THE LABORATORIES OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S PHYSICIAN-SCIENTISTS. 235502031 1176000 EDUCATION: EDUCATION IS A VITAL PART OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S MISSION. OUR TRAINING PROGRAMS PREPARE PHYSICIANS AND SCIENTISTS FOR CAREERS IN THE BIOMEDICAL SCIENCES. OUR COLLABORATIONS WITH THE ROCKEFELLER UNIVERSITY, CORNELL UNIVERSITY, AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY OFFER PHD PROGRAMS IN CHEMICAL BIOLOGY, COMPUTATIONAL BIOLOGY AND MEDICINE, AND THE MEDICAL SCIENCES. THE CENTER ALSO PARTNERS WITH WEILL MEDICAL COLLEGE AND THE ROCKEFELLER UNIVERSITY TO OFFER A MD/PHD DEGREE FOR ASPIRING PHYSICIAN-SCIENTISTS. THE CENTER HAS A PHD PROGRAM IN CANCER BIOLOGY THROUGH ITS LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES. THIS NOVEL PROGRAM, HAS BEEN ENROLLING STUDENTS SINCE 2006, TRAINS BASIC LABORATORY SCIENTISTS TO WORK IN RESEARCH AREAS DIRECTLY RELEVANT TO CANCER AND OTHER HUMAN DISEASES. WE ALSO OFFER POSTGRADUATE CLINICAL FELLOWSHIPS TO TRAIN PHYSICIANS WHO SEEK SPECIAL EXPERTISE IN A PARTICULAR TYPE OF CANCER AND POSTGRADUATE RESEARCH FELLOWSHIPS THAT PROVIDE PHYSICIANS AND SCIENTISTS WITH ADVANCED LABORATORY RESEARCH TRAINING. WITH FACULTY APPOINTMENTS AT THE WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY, OUR CLINICAL STAFF ALSO TRAIN RESIDENTS AND MEDICAL STUDENTS. 4071294539 true true false true false false false false false true true true false false true false false true true false true false false true true false true true true true true true false false false false false false false true true true true false false false true true true true false false true X 1433 0 true 19404 true true true true LU false false false true true false false false false X 113 103 false false false false true true false true true false false true true true true true true true true true true AK AZ AR FL GA IL KS LA MD MA MI MN MS MO NV NH NJ NM NY ND OH OK PA RI SC TN TX UT WA WI X X MARK K SVENNINGSON 6462273414 633 3RD AVENUE NEW YORK NY 10017 RICHARD I BEATTIE SEE SCHEDULE O 3.0 0.0 X 0 0 0 IAN COOK SEE SCHEDULE O 3.0 0.0 X 0 0 0 STANLEY F DRUCKENMILLER SEE SCHEDULE O 10.0 0.0 X 0 0 0 ANTHONY B EVNIN SEE SCHEDULE O 10.0 0.0 X 0 0 0 ROGER W FERGUSON SEE SCHEDULE O 3.0 0.0 X 0 0 0 WILLIAM E FORD SEE SCHEDULE O 3.0 0.0 X 0 0 0 RICHARD N FOSTER SEE SCHEDULE O 3.0 0.0 X 0 0 0 STEPHEN FRIEDMAN SEE SCHEDULE O 3.0 0.0 X 0 0 0 ELLEN V FUTTER SEE SCHEDULE O 3.0 0.0 X 0 0 0 LOUIS V GERSTNER JR SEE SCHEDULE O 3.0 0.0 X 0 0 0 JONATHAN N GRAYER SEE SCHEDULE O 10.0 0.0 X 0 0 0 JAMIE GREGORY SEE SCHEDULE O 3.0 0.0 X 0 0 0 BENJAMIN W HEINEMAN JR SEE SCHEDULE O 3.0 0.0 X 0 0 0 JEFFREY P JOHNSON SEE SCHEDULE O 3.0 0.0 X 0 0 0 DAVID H KOCH SEE SCHEDULE O 3.0 0.0 X 0 0 0 MARIE-JOSEE KRAVIS SEE SCHEDULE O 3.0 0.0 X 0 0 0 JAMIE C NICHOLLS SEE SCHEDULE O 3.0 0.0 X 0 0 0 JAMES G NIVEN SEE SCHEDULE O 3.0 0.0 X 0 0 0 BRUCE C RATNER SEE SCHEDULE O 3.0 0.0 X 0 0 0 ALEXANDER T ROBERTSON SEE SCHEDULE O 3.0 0.0 X 0 0 0 JAMES D ROBINSON III SEE SCHEDULE O 3.0 0.0 X 0 0 0 VIRGINIA M ROMETTY SEE SCHEDULE O 3.0 0.0 X 0 0 0 STEPHEN C SHERRILL SEE SCHEDULE O 3.0 0.0 X 0 0 0 LAVINIA BRANCA SNYDER SEE SCHEDULE O 3.0 0.0 X 0 0 0 PETER J SOLOMON SEE SCHEDULE O 3.0 0.0 X 0 0 0 JOHN R STRANGFELD SEE SCHEDULE O 3.0 0.0 X 0 0 0 SCOTT M STUART SEE SCHEDULE O 10.0 0.0 X 0 0 0 PETER A WEINBERG SEE SCHEDULE O 3.0 0.0 X 0 0 0 DEBORAH C WRIGHT SEE SCHEDULE O 10.0 0.0 X 0 0 0 CLIFTON S ROBBINS SEE SCHEDULE O 10.0 0.0 X X 0 0 0 NORMAN C SELBY SEE SCHEDULE O 10.0 0.0 X X 0 0 0 DOUGLAS WARNER III SEE SCHEDULE O 10.0 0.0 X X 0 0 0 JOSE BASELGA MD PHD PIC & CHIEF MEDICAL OFFICER 50.0 0.0 X X 2427171 0 250816 MICHAEL P GUTNICK EXECUTIVE VP & CFO 50.0 0.0 X X 2351994 0 81957 KATHRYN MARTIN CHIEF OPERATING OFFICER 50.0 0.0 X X 2816680 0 584614 MARK SVENNINGSON SVP FINANCE & CONTROLLER 50.0 0.0 X X 871533 0 78098 CRAIG B THOMPSON MD PRESIDENT & CEO 50.0 0.0 X X 3878482 0 1443976 KERRY BESSEY SVP & CHIEF HR OFFICER 50.0 0.0 X 1382880 0 74961 ERIC M COTTINGTON PHD SVP RESEARCH & TECHNOLOGY MGMT 50.0 0.0 X 1347828 0 77993 FREDRICK GROVES EVP & HOSPITAL ADMINISTRATOR 50.0 0.0 X 1132491 0 32327 JASON KLEIN SVP-CHIEF INVESTMENT OFFICER 50.0 0.0 X 1691487 0 1526715 CAROLYN B LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 50.0 0.0 X 466978 0 40470 JORGE LOPEZ EVP GENERAL COUNSEL 50.0 0.0 X 1982900 0 71543 EDWARD MAHONEY SVP FACILITIES MGMT & CONST 50.0 0.0 X 1269714 0 69108 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 50.0 0.0 X 842810 0 59799 RICHARD K NAUM SVP DEVELOPMENT 50.0 0.0 X 1691717 0 77806 PATRICIA C SKARULIS SVP-CHIEF INFORMATION OFFICER 50.0 0.0 X 1330498 0 55345 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 50.0 0.0 X 530163 0 35958 MARK BILSKY MD ATTENDING-DEPT OF NEUROSURGERY 50.0 0.0 X 3209703 0 367921 BERNARD BOCHNER MD ATTENDING-SURGERY 50.0 0.0 X 2842055 0 70417 PHILIP GUTIN MD CHAIR & ATTENDING NEUROSURGERY 50.0 0.0 X 2828868 0 57489 HEDVIG HRICAK MD CHAIRMAN ATTENDING-RADIOLOGY 50.0 0.0 X 2520184 0 93569 ANNE MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 50.0 0.0 X 2123138 0 75082 THOMAS KELLY MD LAB MEMBER, FORM. SKI DIRECTOR 50.0 0.0 X 570095 0 80336 ROGER PARKER ESQ EVP & GENERAL COUNSEL 0.0 0.0 X 235556 0 0 40344925 0 5306300 5611 true true false TURNER CONSTRUCTION 375 HUDSON STREET NEW YORK NY 10014 GENERAL CONSTRUCTION 362451371 HUNTER ROBERTS CONSTRUCTION GR LLC 2 WORLD FINANCIAL CENTER NEW YORK NY 10001 GENERAL CONSTRUCTION 75073330 JGN CONSTRUCTION CORP 66-40 69TH STREET MIDDLE VILLAGE NY 11379 GENERAL CONSTRUCTION 14450124 PERKINS EASTMAN ARCHITECTS 115 FIFTH AVENUE NEW YORK NY 10003 ARCHITECTURAL 7381470 IBM CORPORATION NORTH CASTLE DRIVE ARMONK NY 10504 CONSULTING 4857200 228 X 909583 188453000 325399417 3950387 514762000 MEDICAL CARE 622310 3586106000 3586106000 NON-GOVERNMENT SPONSORED RESEARCH 541711 97433000 97433000 3683539000 13970000 -3040577 17010577 10577000 10577000 81491000 81491000 38425000 44146902 -5721902 0 -5721902 -5721902 751583153 586339153 165244000 165244000 165244000 2697000 909583 1024135 1672865 1672865 0 0 0 0 0 0 CAFETERIA 722212 6324000 6324000 VENDOR DISCOUNTS 561439 2007000 2007000 SERVICES PROVIDED 561439 5776000 5776000 19416135 1177209 18238926 33523135 4499057098 3683539000 -1863368 302619466 1000000 1000000 24459000 24459000 0 0 30625822 23806742 4898748 1920332 1203025 1186018 17007 1793309930 1764649138 5971117 22689675 138668157 136678481 648435 1341241 247179353 242048821 1578272 3552260 108616984 106403628 711939 1501417 0 10997554 10439593 459302 98659 846890 715647 130701 542 793599 793599 128216 128216 8440696 8440696 80868201 72554406 987418 7326377 24849930 19255912 5594018 287642087 265804730 5419342 16418015 35844793 35018923 231816 594054 2422500 2422500 119551061 110512934 8751283 286844 11347124 10507226 255054 584844 0 13313264 12189858 610217 513189 45342952 40473776 4869176 0 287145004 278892216 6816058 1436730 -2027174 -2193749 40668 125907 PHARMACEUTICALS 701784166 701784166 MEDICAL/SURGICAL SUPPLIES 200917345 200647083 270262 PROVISION BAD DEBT-REG ASSMT 54254168 54254168 UBIT EXPENSE 397488 397488 -45268037 -40587777 -4616880 -63380 4184654098 4071294539 49310619 64048940 X 15454344 7604925 7849419 456756000 334702000 419984000 805181000 597945000 587401000 451937175 442263000 0 0 0 0 32709000 36387000 56919000 73204000 99389000 118020000 6757747000 2902215000 3359348000 3855532000 3597777000 3502211000 792425000 856740000 20156000 20911000 0 0 0 0 9885345175 10632552000 728200976 876391000 0 0 0 0 1265956000 1439048000 0 0 0 0 0 0 1350000000 1350000000 815201000 864303000 4159357976 4529742000 X 4341317199 4628681000 757725000 798880000 626945000 675249000 5725987199 6102810000 9885345175 10632552000 X 314403000 251283000 -188863199 X false true X true true true X 3 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 131624182 4 true 0 0 MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASES 131624082 3 true 0 0 MEMORIAL SLOAN-KETTERING CANCER CENTER 131924236 3 true 0 0 3 537706930 544924247 437479585 484699242 514556000 2519366004 0 0 537706930 544924247 437479585 484699242 514556000 2519366004 118250663 2401115341 135524730 210605148 245714279 201917796 100111000 893872953 0 0 3413238957 11354311057 0.70347 0.68625 X true false false false false 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SUPPORTED ORGANIZATIONS SUPPORT FROM THE SUPPORTING ORGANIZATIONS RELATE PRINCIPALLY TO THE SHARING OF CERTAIN FACILITIES, EQUIPMENT, PERSONNEL COSTS, EDUCATION, INSURANCE AND ALLOCATIONS. AMOUNTS DUE TO OR DUE FROM AFFILIATES RESULTING FROM THESE SERVICES DO NOT BEAR INTEREST. SUPPORTING ORGANIZATIONS NAME OF SUPPORTING ORGANIZATION EIN TYPE S.K.I. REALTY 13-3389586 11a MSK INSURANCE US 83-0363317 11a MSKCC PROTON INC. 35-2397819 11a MSKCC PROPERTIES, LLC. 35-2464610 11a false true false false false false true 464792 false true 328807 793599 false LOBBYING COSTS MSKCC ENGAGES IN FEDERAL, STATE AND LOCAL LOBBYING. THE CENTER'S FEDERAL LOBBYING EFFORT FOCUSES ON PATIENT CARE AND REIMBURSEMENT ISSUES. PATIENT CARE ADVOCACY INCLUDES ENSURING PATIENTS ARE ABLE TO ACCESS CLINICAL TRIALS AND CANCER HOSPITALS ARE ABLE TO EFFECTIVELY RESEARCH POTENTIAL TREATMENTS FOR CANCER AS WELL AS PREVENTIVE AND PALLIATIVE MEASURES. THE CENTER ALSO SEEKS TO RECEIVE EQUITABLE REIMBURSEMENT FOR SERVICES RENDERED TO PATIENTS ENROLLED IN ENTITLEMENT PROGRAMS. FROM TIME TO TIME THE CENTER WEIGHS IN ON OTHER FEDERAL LEGISLATION THAT IMPACTS CANCER CARE AND HOSPITALS IN GENERAL. THE CENTER'S STATE LOBBYING EFFORT CONCENTRATES ON LEGISLATION THAT IMPACTS PROVIDERS' ABILITIES TO EFFECTIVELY CARE FOR PATIENTS, SUCH AS LEGISLATION THAT AMENDS CONSTRUCTION REVIEW PROCEDURES, PROVIDES FUNDING FOR BLOOD DONATION DRIVES, OR ENCOURAGES COLLABORATION BETWEEN CARE PROVIDERS AT HOSPITAL FACILITIES. STATE EFFORTS ALSO FOCUS ON ADVOCATING FOR HEALTH CARE ISSUES DURING STATE BUDGET NEGOTIATIONS. LOCAL LOBBYING IS PERFORMED BY THE GREATER NEW YORK HOSPITAL ASSOCIATION ON BEHALF OF ITS MEMBERS. PART II-B LINE 1(I) OTHER ACTIVIES LOBBYING PORTION OF DUES PAID IN 2017 GREATER NEW YORK HOSPITAL ASSOCIATION $317,968 NYSSA 7,685 AMERICAN COLLEGE OF SURGEONS 1,022 OTHERS 2,132 TOTAL $328,807 false false 802748000 52800000 13508000 869056000 778565000 18986000 5197000 802748000 772740000 17561000 -2097000 9639000 778565000 753249000 25760000 9616000 15885000 772740000 709754000 56687000 44303000 57495000 753249000 0.22300 0.77700 true true true 380703000 380703000 4696983000 1668675000 3028308000 116464000 67052000 49412000 1563597000 1166488000 397109000 3855532000 PRIVATE EQUITY & VENTURE CAP. 844840000 F NONMARKETABLE SECURITIES 11900000 C 856740000 0 PENSION AND POSTRETIREMENT 436202000 INSURANCE RESERVES 292601000 DEFERRED COMPENSATION 70299000 ASSET RETIREMENT OBLIGATIONS 38621000 DEFERRED GIFT ANNUITY 19187000 OTHER LIABILITIES 7393000 864303000 4779696135 251283000 45250037 296533037 4483163098 15894000 15894000 4499057098 4213028135 45268037 45268037 4167760098 15894000 1000000 16894000 4184654098 USE OF ENDOWMENT FUNDS PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. OTHER PART XI LINE 2D REVENUE RENTAL EXPENSES OFFSETS REVENUE $44,146,902 FUNDRAISING COSTS OFFSETS REVENUE 1,024,135 MMPC REVENUE NOT INCLUDED IN 990 79,000 TOTAL $45,250,037 PART XII LINE 2D EXPENSES RENTAL EXPENSES OFFSETS REVENUE $44,146,902 FUNDRAISING COSTS OFFSETS REVENUE 1,024,135 MMPC EXPENSES NOT INCLUDED IN 990 97,000 TOTAL $45,268,037 PART XII LINE 4B PAYMENT OF A GRANT TO THE RALPH LAUREN CENTER FOR $1,000,000 RECORDED AS NON OPERATING EXPENSE. FIN 48 LIABILITY FOR UNCERTAIN TAX POSITIONS A FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS. true true true true true true true false false false false false false false false false false true NONDISCRIMINATORY POLICY THE SCHOOL'S NONDISCRIMINATORY POLICY IS PUBLICIZED ON ITS WEB SITE: HTTP://WWW.SLOANKETTERING.EDU/GERSTNER/HTML/54499.CFM. ALL APPLICANTS TO THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES ARE CONSIDERED ON THE BASIS OF MERIT. THE SCHOOL DOES NOT DISCRIMINATE ON THE BASIS OF GENDER, RACE, COLOR, CREED, RELIGION, AGE, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS, MARITAL STATUS, SEXUAL ORIENTATION, OR CITIZENSHIP STATUS IN ACCORDANCE WITH INSTITUTIONAL POLICY AND IN COMPLIANCE WITH THE REQUIREMENTS OF THE CIVIL RIGHTS ACT, THE EDUCATION ADMENDMENTS, THE REHABILITATION ACT, THE AGE DISCRIMINATION ACT, AND THE AMERICANS WITH DISABILITIES ACT. East Asia and the Pacific Program Services PATIENT CARE CONF 229748 South America Program Services PATIENT CARE CONF 82944 Europe (Including Iceland and Greenland) Program Services RESEARCH CONFERENCES 554795 South Asia Program Services RESEARCH CONFERENCES 1735 East Asia and the Pacific Program Services INVESTMENT MEETINGS 37196 Europe (Including Iceland and Greenland) Program Services INVESTMENT MEETINGS 62387 South Asia Program Services INVESTMENT MEETINGS 12580 North America Program Services INVESTMENT MEETINGS 12861 East Asia and the Pacific Program Services RESEARCH CONFERENCES 133785 Middle East and North Africa Program Services RESEARCH CONFERENCES 53312 North America Program Services RESEARCH CONFERENCES 46460 South America Program Services RESEARCH CONFERENCES 19704 Central America and the Caribbean Program Services PATIENT CARE CONF 1589 Europe (Including Iceland and Greenland) Program Services PATIENT CARE CONF 725520 Middle East and North Africa Program Services PATIENT CARE CONF 24497 North America Program Services PATIENT CARE CONF 87932 Russia and the Newly Independent States Program Services PATIENT CARE CONF 8844 South Asia Program Services PATIENT CARE CONF 43842 Sub-Saharan Africa Program Services PATIENT CARE CONF 93613 Central America and the Caribbean Investments 1488688408 Europe (Including Iceland and Greenland) Investments 44602899 Sub-Saharan Africa Investments 4049892 2095889 1537478654 1539574543 true false true true true false ORGANIZATION'S PROCEDURES FOR THE USE OF FUNDS OUTSIDE THE US MEMORIAL SLOAN-KETTERING CANCER CENTER DOES NOT MAKE GRANTS OR USE GRANT MONEY OUTSIDE OF THE UNITED STATES. INVESTMENTS BY REGION VALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31. X X X X X X X true DONOR SERVICES 1200 WILLSHIRE BLVD LOS ANGELES CA 90017 TELEMKT. false 693017 128216 564801 693017 128216 564801 All States SPRING BALL 1090650 177400 913250 100212 37350 72125 FALL BALL 666994 204354 462640 137854 87412 5 1848939 527829 1321110 226448 122953 5350 234431 3606583 909583 2697000 364302 223165 42700 393968 1024135 1672865 true true X true X 500. true X 500. true true false true true 19877054 3673019 16204035 0.00390 225862934 95237052 130625882 0.03150 245739988 98910071 146829917 0.03540 15222196 15222196 0.00370 235502031 45075942 190426089 0.04600 3875816 3875816 0.00090 528360620 321752741 206607879 0.04990 1880550 1880550 0.00050 784841213 366828683 418012530 0.10100 1030581201 465738754 564842447 0.13640 844 844 30778 30778 208900 5400 203500 119127 119127 124017 124017 483666 5400 478266 0.00010 false 80297269 4925000 890725129 1200151743 -309426614 X true true 1 1 MEMORIAL HOSP FOR CANCER & ALLIED DIS 1275 YORK AVENUE NEW YORK NY 10065 www.mskcc.org 7002020H X X X X MEMORIAL HOSP FOR CANCER & ALLIED DIS 1 false false true X X X X X X X X X X 16 true false false true X www.mskcc.org/communityserviceplans X X true 16 true www.mskcc.org/communityserviceplans false true X 500. 500. X X X X X X true true X X X X true X SEE SCH H, PART V, SECTION C X www.mskcc.org/financial-assistance X SEE SCH H, PART V, SECTION C X X X X X X true X false X X X X true X false false PART V FACILITY INFORMATION SECTION C. SUPPLEMENTAL INFORMATION FOR PART V, SECTION B. LINE 3 MSK CONDUCTED A COMMUNITY HEALTH NEEDS ASSESSMENT IN THE FALL OF 2016 TO DETERMINE THE CRITICAL CANCER-RELATED HEALTH CONCERNS FACING RESIDENTS IN OUR 23-COUNTY CATCHMENT AREA IN NEW YORK, NEW JERSEY, AND CONNECTICUT. WE ANALYZED CANCER STATISTICS ON INCIDENCE, PREVALENCE, AND MORTALITY. WE ALSO REVIEWED KEY HEALTH TRENDS AMONG CANCER PATIENTS, MULTICULTURAL POPULATIONS, AND THE PUBLIC. LINE 5 TO ENGAGE THE BROAD COMMUNITY IN OUR HEALTH NEEDS ASSESSMENT, MSK HELD A SERIES OF COMMUNITY FORUMS IN HARLEM, BROOKLYN, AND MANHATTAN, AS WELL AS WEBINARS WITH FURTHER REACHES TO OUR CATCHMENT AREAS IN LONG ISLAND, WESTCHESTER AND NEW JERSEY. THESE FORUMS WERE CONDUCTED TO CONNECT WITH REPRESENTATIVES FROM COMMUNITY-BASED ORGANIZATIONS INCLUDING PRIVATE, NON-PROFIT, PUBLIC, AND GOVERNMENT AGENCIES THAT WORK TO MEET COMMUNITY NEEDS WITH SERVICES AND RESOURCES THROUGHOUT NEW YORK CITY AND ITS SURROUNDING COMMUNITIES. REPRESENTATIVES FROM 22 COMMUNITY-BASED ORGANIZATIONS PARTICIPATED IN THE FORUMS AND SERVE A DIVERSE RANGE OF CLIENTS. SERVICES PROVIDED BY THESE ORGANIZATIONS INCLUDE CANCER SUPPORT SERVICES, DOMESTIC VIOLENCE SUPPORT, IMMIGRATION ASSISTANCE, AND PRIMARY CARE SERVICES. COMMUNITY ORGANIZATIONS THAT PROVIDED INPUT ON MSK'S HEALTH NEEDS ASSESSMENT INCLUDE: AMERICAN CANCER SOCIETY - LONG ISLAND CHAPTER AMERICAN CANCER SOCIETY - NEW YORK CITY CHAPTER ARAB AMERICAN FAMILY SUPPORT CENTER BRONX HEALTH REACH BROOKLYN COMMUNITY SERVICES CANCER AND CAREERS CANCER CARE COALICION MEXICANA COMMUNITY ACTION NETWORK - HEALTHY START BROOKLYN FRIENDS OF KAREN GILDA'S CLUB HARLEM UNITED HISPANIC FEDERATION MAKE THE ROAD NEW YORK MEXICAN CONSULATE NATIONAL OVARIAN CANCER COALITION NEW YORK CITY DEPARTMENT OF HEALTH & MENTAL HYGIENE NEW YORK CITY FAMILY JUSTICE CENTER SHARE THE CREATIVE CENTER THE LEUKEMIA & LYMPHOMA SOCIETY QUEENS LIBRARY LINE 7D SUMMARY FINDINGS OF MSK'S CHNA WERE SENT TO COMMUNITY-BASED ORGANIZATIONS WITH WHOM WE WORK AND WERE ALSO INCORPORATED INTO OUR ANNUAL COMMUNITY SERVICE PLAN (CSP). THE CSP IS DISTRIBUTED TO LOCAL ELECTED OFFICIALS, ORGANIZATIONS AND IS AVAILABLE TO THE PUBLIC AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. THE CHNA WAS ALSO PUBLICIZED THROUGH OUR COMMUNITY NEWSLETTERS WHICH ARE DISTRIBUTED TO APPROXIMATELY 50,000 RESIDENTS NEAR OUR TREATMENT FACILITIES. LINE 11 THE CHNA FOUND THAT MSK IS CURRENTLY ADDRESSING MANY AREAS OF NEED INCLUDING COLLABORATIVE INITIATIVES, FINANCIAL INFORMATION/ASSISTANCE, PREVENTION PROGRAMS, TRANSPORTATION AND PATIENT NAVIGATION. IN ADDITION, MSK HAS IDENTIFIED SOME NEW AREAS OF FOCUS BECAUSE OF THE CHNA. THESE INCLUDE KNOWLEDGE GATHERING AND NEW PROGRAMMING TO REACH MULTICULTURAL POPULATIONS SPECIFICALLY TARGETED TO THE HISPANIC POPULATION IN OUR SERVICE AREA; ENHANCED COLLABORATIONS WITH COMMUNITY-BASED ASSOCIATIONS; FINANCIAL ASSISTANCE AWARENESS; CANCER SCREENING AMONG UNDERSERVED POPULATIONS; INCREASE PARTICIPATION IN MSK'S SMOKING CESSATION SERVICES; AND EDUCATIONAL MATERIALS FOR MULTICULTURAL AUDIENCES IN SPANISH AND RUSSIAN. ADDITIONAL INFORMATION ON IDENTIFIED NEEDS AND WHAT NEEDS ARE NOT BEING ADDRESSED TOGETHER WITH THE REASON WHY SUCH NEEDS ARE NOT BEING ADDRESSED CAN BE FOUND IN THE HOSPITAL'S MOST RECENT COMPREHENSIVE THREE-YEAR CSP AND CHNA REPORT POSTER AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. IDENTIFIED NEEDS THAT MSK CANNOT ADDRESS ADEQUATELY BECAUSE THEY ARE BEYOND OUR SCOPE OF SERVICE ARE LEGAL ADVOCACY, POLITICAL ADVOCACY, AND SUPPORT SERVICES FOR CRISIS INTERVENTION. WITHIN THESE CONSTRAINTS, MSK PROVIDES REFERRALS TO EXTERNAL ORGANIZATIONS THAT RESPOND TO THESE NEEDS. LINE 13G NEW PATIENTS WHO RESIDE IN NEW YORK OR NEW JERSEY MAY QUALIFY FOR FINANCIAL ASSISTANCE. EXISTING PATIENTS MAY QUALIFY FOR AID REGARDLESS OF WHERE THEY LIVE IN THE UNITED STATES. LINE 15E FOR MANY YEARS MSK HAS PROVIDED FINANCIAL HELP TO PATIENTS IN NEED. OUR FINANCIAL ASSISTANCE PROGRAM (FAP) AIDS UNINSURED AND UNDERINSURED PATIENTS WITH HOUSEHOLD INCOME UP TO FIVE TIMES THE FEDERAL POVERTY LEVEL (FPL) WHO CANNOT GET PUBLICLY FUNDED HEALTH INSURANCE OR CANNOT AFFORD TO PAY FOR THEIR MEDICAL CARE. TO BE CONSIDERED FOR THE FAP, PATIENTS ARE ASKED TO PROVIDE CERTAIN PERTINENT DOCUMENTATION TO ASSIST IN DETERMINING THEIR ELIGIBILITY AND THE AMOUNT OF FINANCIAL ASSISTANCE THEY ARE QUALIFIED TO RECEIVE. TO FURTHER ENHANCE THE PROCESS, WE STRATEGICALLY PLACE FINANCIAL ASSISTANCE BROCHURES AT EACH REGISTRATION SITE AND AT THE FRONT DESK OF PATIENT FINANCIAL SERVICES OFFICE. WE INCLUDE COPIES OF THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT. MENTION OF THE FAP IS ALSO MADE IN EVERY PATIENT STATEMENT AND LETTER SENT TO THEM AS WELL AS IN THE COLLECTION LETTERS FROM COLLECTION AGENCIES. FURTHERMORE, THE FINANCIAL ASSISTANCE INFORMATION IS POSTED ON THE MSK WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE. LINE 16 THE PLAN LANGUAGE SUMMARY AND THE APPLICATION ARE AVAILABLE ON OUR WEBSITE AT: WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE. A PATIENT CAN ALSO REQUEST A COPY BY CALLING OUR DEDICATED FINANCIAL ASSISTANCE LINE AT 212-639-3810. LINE 20E NEITHER MSK NOR ITS COLLECTION AGENCIES PURSUE ANY EXTRAORDINARY COLLECTION ACTIONS AGAINST ITS PATIENTS. PRIOR TO REFERRING A PATIENT'S ACCOUNT TO A COLLECTION AGENCY MSK SENDS THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT TO MAKE THEM AWARE OF THE CHARITY CARE/FINANCIAL ASSISTANCE PROGRAM. THE FAP IS MENTIONED IN EVERY PATIENT STATEMENT AND LETTER THAT IS SENT TO A PATIENT. THE FAP IS ALSO MENTIONED IN EVERY COLLECTION LETTER SENT TO PATIENTS BY THE COLLECTION AGENCIES. EVEN AFTER A PATIENT'S ACCOUNT IS SENT TO COLLECTIONS, SHE/HE CAN STILL APPLY FOR FINANCIAL ASSISTANCE. IT IS NEVER TOO LATE TO APPLY FOR FINANCIAL ASSISTANCE AND IF ELIGIBLE, RETROACTIVE FAP COVERAGE WOULD BE PROVIDED TO THE PATIENT. LINE 21 ALL MSK'S PATIENTS REQUIRING URGENT CARE ARE PROVIDED WITH THE SERVICE REGARDLESS OF THEIR INSURANCE AND/OR FINANCIAL LIMITATION. FURTHERMORE, SERVICES ARE PROVIDED EVEN IF A DETERMINATION REGARDING ELIGIBILITY FOR MSK'S FAP HAS NOT YET BEEN MADE. LINE 22B ALL PATIENTS ARE ADVISED OF MSK'S FAP THOUGH THE DETERMINATION OF A CASE IS ONLY DOCUMENTED IF THE PATIENT APPLIES FOR THE PROGRAM. THE MAXIMUM AMOUNT CHARGED TO PATIENTS DEEMED ELIGIBLE FOR FAP "FOR EMERGENCY OR OTHER MEDICALLY NECESSARY CARE" IS THE AMOUNT THE INSTITUTION INITIALLY CONCLUDED THE PATIENT CAN AFFORD TO PAY WHEN FINALIZING THEIR FAP APPLICATION. THIS AMOUNT IS DERIVED BY CALCULATING A PATIENT'S HOUSEHOLD "NET MONTHLY INCOMEDEDUCTING THE TOTAL AMOUNT OF THEIR ROUTINE MONTHLY BILLS. THE AMOUNT REMAINING IS WHAT WE CONSIDER THE PATIENT CAN PAY EACH MONTH. IF THE PATIENT'S HOUSEHOLD MONTHLY ROUTINE BILLS ARE MORE THAN OR EQUAL TO "NET MONTHLY INCOME", THE INSTITUTION ACCEPTS WHATEVER THE PATIENT'S INSURANCE PAYS AS PAYMENT IN FULL, (THE PATIENT WOULD NOT HAVE TO PAY ANYTHING OUT OF POCKET); UNLESS THE PATIENT HAS ASSETS SUCH AS A SECOND HOME, STOCKS, CERTIFICATE OF DEPOSITS, LARGE SAVINGS OR ANY OTHER ASSETS EXCLUDING RETIREMENT AND EDUCATION ACCOUNTS. PATIENTS WITH LARGE AMOUNTS OF ASSETS WHOSE ROUTINE MONTHLY BILLS ARE GREATER THAN THEIR "NET MONTHLY INCOME" MAY BE ELIGIBLE FOR REDUCED TIME AND PAYMENT ARRANGEMENT AND WOULD MAKE MONTHLY PAYMENTS FOR (12 TO 18 MONTHS) TO PAY OFF THE AMOUNT THE INSTITUTION DETERMINED THEY CAN AFFORD TO PAY. ONCE THE FAP APPLICATION IS FINALIZED AND A PATIENT IS DEEMED ELIGIBLE TO PAY NOTHING OR A REDUCED TIME PAYMENT, THIS AGREEMENT IS EFFECTIVE FOR ONE YEAR AND INCLUDES BALANCES THE PATIENT HAD OUTSTANDING. ALL PATIENTS ARE ADVISED OF MSK'S FAP AND THE DETERMINATION IS DOCUMENTED ONLY IF THE PATIENT APPLIES. 19 ROCKEFELLER OUTPATIENT PAVILION 160 EAST 53RD STREET NEW YORK NY 10022 EXTENSION CLINIC MSK COMMACK 650 COMMACK ROAD COMMACK NY 11725 EXTENSION CLINIC EVELYN H LAUDER BREAST CTR & MSK IMAGIN 300 E 66 STREET NEW YORK NY 10065 EXTENSION CLINIC MSK WESTCHESTER 500 WESTCHESTER AVENUE WEST HARRISON NY 10604 EXTENSION CLINIC MSK BASKING RIDGE 136 MOUNTAIN VIEW BLVD BASKING RIDGE NJ 07920 EXTENSION CLINIC JOSIE ROBERTSON SURGERY CENTER 1133 YORK AVENUE NEW YORK NY 10065 EXTENSION CLINIC MSK MONMOUTH 480 RED HILL ROAD MIDDLETOWN NJ 07748 EXTENSION CLINIC 64TH STREET OUTPATIENT CENTER 205 EAST 64TH STREET NEW YORK NY 10065 EXTENSION CLINIC SIDNEY KIMMEL CTR FOR PROSTATE & UROLOGI 353 EAST 68TH STREET NEW YORK NY 10065 EXTENSION CLINIC MSK ROCKVILLE CENTER 1000 NORTH VILLAGE AVENUE ROCKVILLE CENTER NY 11570 EXTENSION CLINIC 60TH STREET OUTPATIENT CENTER 16 EAST 60TH STREET NEW YORK NY 10022 EXTENSION CLINIC BROOKLYN INFUSION CENTER 557-1 ATLANTIC AVENUE BROOKLYN NY 11217 EXTENSION CLINIC SILLERMAN CENTER FOR REHABILITATION 515 MADISON AVENUE NEW YORK NY 10022 EXTENSION CLINIC MSK HAUPPAUGE 800 VETERANS MEMORIAL HIGHWAY HAUPPAUGE NY 11788 EXTENSION CLINIC BREAST EXAMINATION CENTER OF HARLEM 163 WEST 125TH STREET NEW YORK NY 10027 EXTENSION CLINIC MSK COUNSELING CENTER 641 LEXINGTON AVENUE NEW YORK NY 10022 EXTENSION CLINIC 55TH STREET IMAGING CENTER 301 EAST 55TH STREET NEW YORK NY 10022 EXTENSION CLINIC POST TREATMENT RESOURCES PROGRAM 215 EAST 68TH STREET NEW YORK NY 10065 EXTENSION CLINIC BENDHEIM CENTER FOR INTEGRATIVE MEDICINE 1429 FIRST AVENUE NEW YORK NY 10021 EXTENSION CLINIC SCHEDULE H PART VI, LINE 7 PART 1, LINE 3C PATIENT WITH INCOME LESS THAN OR EQUAL TO 500% OF THE FEDERAL POVERTY GUIDELINES (FPG) IS ELIGIBLE FOR THE INSTITUTION'S FINANCIAL ASSISTANCE PROGRAM (FAP). THE INSTITUTION MAY REDUCE THE FEES INCURRED BY THE PATIENT OR ACCEPT AS FULL PAYMENT AMOUNTS PAID BY THE INSURANCE CARRIER ON THE PATIENT'S BEHALF. IN ADDITION, A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. THE INSTITUTION ADJUSTS PATIENTS' INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE "DISPOSABLE INCOME". MSK ALSO DEDUCTS A SPECIFIC AMOUNT (DEBT BURDEN) AS A MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENT'S FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. FAMILY ALLOWED RESOURCE SIZE INCOME LEVELS 1 $ 60,300 $ 37,125 2 $ 81,200 $ 54,375 3 $ 102,100 $ 62,532 4 $ 123,000 $ 70,687 5 $ 143,900 $ 78,845 6 $ 164,800 $ 87,000 PART I, LINE 7G MEMORIAL SLOAN KETTERING HAS CONSISTENTLY SET THE STANDARD OF CARE FOR PEOPLE WITH CANCER BY EMPHASIZING EARLY DETECTION, PRECISE DIAGNOSIS, AND INDIVIDUALLY TAILORED TREATMENT. THE HOSPITAL SUBSIDIZES CANCER SCREENING, TREATMENT, AND SUPPORT SERVICES TO FULFILL ITS MISSION AND TO HELP REDUCE CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. MSK'S BREAST EXAMINATION CENTER OF HARLEM (BECH) PROVIDES BREAST AND CERVICAL CANCER SCREENING, COUNSELING, AND PATIENT FOLLOW-UP, AS WELL AS EDUCATIONAL PROGRAMS TO UNINSURED PATIENTS THROUGHOUT THE NEW YORK CITY AREA. BECH HAS A DEDICATED STAFF, INCLUDING A HEALTH EDUCATOR WHOSE ROLE IS TO INITIATE AND IMPLEMENT OUTREACH ACTIVITIES IN HARLEM AND THE SURROUNDING COMMUNITIES. SINCE ITS INCEPTION IN 1979, BECH HAS HAD MORE THAN 243,396 VISITS, WITH 1,932 OF THOSE VISITS TAKING PLACE IN 2017. ALL SERVICES WERE PROVIDED AT NO OUT-OF-POCKET EXPENSE TO THE WOMEN WHO RECEIVED CANCER SCREENING AND FOLLOW-UP SERVICES. LOCATED IN HARLEM, THE RALPH LAUREN CENTER FOR CANCER CARE (RLC) OFFERS CANCER SCREENING AND TREATMENT SERVICES TO ITS MEDICALLY UNDERSERVED COMMUNITY. THE RLC, MADE POSSIBLE IN PART THROUGH A GIFT FROM THE POLO RALPH LAUREN CORPORATION, IS SOLELY OWNED AND MANAGED BY MSK. SINCE ITS INCEPTION, RLC HAS CONDUCTED MORE THAN 155,202 VISITS, OF WHICH APPROXIMATELY 11,387 OCCURRED IN 2017. RLC CONTINUES TO PROVIDE CARE TO INDIVIDUALS ON MEDICAID AND MEDICAID MANAGED CARE PROGRAMS. TO BETTER SERVE THE NEEDS OF DIAGNOSED PATIENTS, THE RALPH LAUREN CENTER HAS EXPANDED ITS NAVIGATION EFFORTS BY CREATING A MULTIDISCIPLINARY TEAM FOR EACH ONCOLOGIST, CONSISTING OF A CLINICAL NURSE NAVIGATOR AND LAY NAVIGATOR. BOTH NAVIGATORS ASSIST PATIENTS FROM THE TIME OF DIAGNOSIS TO COMPLETION OF TREATMENT AND BEYOND. THE CLINICAL NAVIGATOR FOCUSES ON MEDICAL ISSUES, WORKING WITH THE ONCOLOGIST TO ENSURE THAT PATIENTS UNDERSTAND THEIR DIAGNOSIS AND TREATMENT PLAN. THE LAY NAVIGATOR WORKS WITH THE PATIENTS TO ELIMINATE BARRIERS SUCH AS TRANSPORTATION AND LINKING PATIENTS TO SERVICES IN THE COMMUNITY AS DEEMED NECESSARY. TOGETHER THEY WILL ENSURE THAT THE PATIENTS HAVE THE BEST OUTCOME FROM DIAGNOSIS THROUGH SURVIVORSHIP. THE CENTER CONTINUES TO ASSESS INDIVIDUALS WHO ARE UNINSURED TO BETTER SERVE THEIR MEDICAL NEEDS. NEW PATIENTS ARE SCREENED BY A FINANCIAL NAVIGATOR WHO HELPS PATIENTS EITHER APPLY FOR MEDICAID IF THEY QUALIFY OR THE AFFORDABLE CARE ACT. TO-DATE THE CENTER HAS FINANCIALLY ASSESSED MORE THAN 1,934 PATIENTS. MEMORIAL SLOAN KETTERING'S PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL AND SOCIAL SUPPORT SERVICES TO PATIENTS, THEIR FAMILIES, AND CAREGIVERS. ALL MEDICAID OUTPATIENT VISITS AND INPATIENT ENCOUNTERS ARE SUBSIDIZED BY MSK, AS ARE UNREIMBURSED TIME AND EFFORT BY NURSES TO STAFF A SMOKING CESSATION CLINIC. APPROXIMATELY 1,419 PATIENTS AGREED TO PARTICIPATE IN TREATMENT BY THE NURSING STAFF DURING 2017. PHILANTHROPIC FUNDS ARE USED TO SUPPORT A SIGNIFICANT NUMBER OF THE DEPARTMENT'S OVERALL CLINICAL AND TRAINING ACTIVITIES. THE TOTAL RELATED PERSONAL COST WAS $2.9M. THE INTEGRATIVE MEDICINE SERVICE PROVIDES FREE CLINICAL CARE FOR INPATIENTS AND OUTPATIENTS. DURING 2017, THE SERVICE PROVIDED 13,518 TREATMENTS WITH A RELATED PERSONAL COST OF $962,000. THE CLINICAL SERVICES PROVIDED INCLUDE MUSIC THERAPY, TOUCH THERAPY, ACUPUNCTURE, YOGA AND YOGIC BREATHING, MEDITATION, GUIDED IMAGERY, KARATE, AND DANCE THERAPY. A TOUCH THERAPY FOR CAREGIVERS' COURSE IS OFFERED FREE OF CHARGE TO ANY INPATIENT AND THEIR FAMILY MEMBERS ONCE PER MONTH. PART I, LINE 7, COLUMN (F) THE AMOUNT OF THE BAD DEBT EXPENSE REMOVED FROM THE 2017 CALCULATION IS $43,474,000. PART I, LINE 7 FINANCIAL ASSISTANCE REPRESENTS THE COST OF SERVICES PROVIDED TO PATIENTS WHO CANNOT AFFORD HEALTH CARE SERVICES DUE TO INADEQUATE RESOURCES AND/OR ARE UNINSURED OR UNDERINSURED. A PATIENT IS CLASSIFIED AS A FINANCIAL ASSISTANCE PATIENT IN ACCORDANCE WITH THE INSTITUTION'S ESTABLISHED POLICIES AND WHERE INSUFFICIENT PAYMENT FOR SUCH SERVICES IS ANTICIPATED. THE INSTITUTION CONSIDERS PATIENTS FOR FINANCIAL ASSISTANCE IF HOUSEHOLD INCOME IS LESS THAN 500% OF THE FEDERAL POVERTY GUIDELINES. SERVICES PROVIDED AS FINANCIAL ASSISTANCE ARE NOT REPORTED AS REVENUE. THE COSTS REPORTED IN THE TABLE ON LINE 7, WERE BASED ON VARIOUS SOURCES. FINANCIAL ASSISTANCE AND UNREIMBURSED MEDICAID AND MEDICARE COMMUNITY BENEFITS COST WERE BASED ON A COST TO CHARGE RATIO CALCULATION. THE TOTAL CHARGES ASSOCIATED WITH THESE PROGRAMS ARE MULTIPLIED BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. THE COSTS ASSOCIATED WITH A PORTION OF THE HEALTH PROFESSIONAL EDUCATION COMMUNITY BENEFIT ARE OBTAINED FROM THE STEP-DOWN OF COSTS PREPARED AS PART OF THE NEW YORK STATE INSTITUTIONAL COST REPORT. COST OF PROVIDING FINANCIAL ASSISTANCE AS CALCULATED PER THE ABOVE IS NET OF AMOUNTS RECEIVED FROM THE NEW YORK STATE BAD DEBT AND CHARITY CARE POOLS. TO ARRIVE AT THE AMOUNTS REPORTED IN THE TABLE ON LINE 7, ADDITIONAL STEPS AS OUTLINED BELOW WERE TAKEN. UNPAID COST OF GOVERNMENT-SPONSORED HEALTH CARE REPRESENTS THE ESTIMATED DIFFERENCE BETWEEN THE PAYMENTS MADE UNDER THE MEDICARE AND MEDICAID PROGRAMS AND THE INSTITUTION'S COST OF PROVIDING THESE SERVICES AS CALCULATED ABOVE. THE INSTITUTION SUBTRACTS ALL REVENUES RECEIVED FROM THE MEDICARE AND MEDICAID PROGRAMS TO DETERMINE THE COMMUNITY BENEFIT PROVIDED. RESEARCH COMMUNITY BENEFIT COSTS REPRESENT ALL COSTS FOR BASIC TRANSLATIONAL AND CLINICAL RESEARCH, SUPPORTED BY INSTITUTIONAL FUNDS, GOVERNMENTAL, AND OTHER NON-PROFIT ORGANIZATIONS. RESEARCH COSTS SUPPORTED BY PHILANTHROPIC FUNDS, TOTALING $127.8M ARE NOT INCLUDED IN SCHEDULE H, PART 1, LINE 7. THE INSTITUTION IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTION TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS, RADIOLOGY STUDENTS, NURSING STUDENTS, SOCIAL WORK STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER BIOLOGY. THE AMOUNTS REPORTED AS HEALTH TRAINING REPRESENT INSTITUTIONAL FUNDS, AS WELL AS COSTS MORE THAN AMOUNTS REIMBURSED BY THIRD-PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. AS INDICATED EARLIER, MSK'S PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL SERVICES AND OTHER QUALIFYING SUBSIDIZED COMMUNITY BENEFIT PROGRAMS TO PATIENTS. SUBSIDIZED CANCER SCREENINGS ARE ALSO OFFERED AT THE INSTITUTION'S OTHER OUTPATIENT FACILITIES. THE COST ASSOCIATED WITH THESE PATIENTS' CARE ARE REPORTED IN THE TABLE ON LINE 7, BASED ON PATIENT CARE COST TO CHARGE. ALL SALARY EXPENSES RELATED TO OTHER SUBSIDIZED PATIENT CARE BY ATTENDING PHYSICIANS, CLINICAL AND RESEARCH FELLOWS AND NURSE PRACTITIONERS ARE ALSO REPORTED IN THE TABLE ON LINE 7G. PART II MSK ENGAGES IN AND SUPPORTS COALITION BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES THE INSTITUTION SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF MEMBERS SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE AMERICAN PUBLIC HEALTH ASSOCIATION, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR TYPES OF CANCER. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. PART III, LINE 2 THE AMOUNT ON LINE 2 OF PART III IS THE ACTUAL 2017 BAD DEBT WRITE-OFF WHICH IS DERIVED BY TAKING THE GROSS CHARGES ASSOCIATED WITH THE PROVISIONS FOR BAD DEBTS AND MULTIPLYING BY A RATIO OF HISTORICAL EXPENSES TO CHANGES AS DERIVED FROM THE HOSPITAL'S NEW YORK STATE INSTITUTIONAL COST REPORT. A SEPARATE RATIO IS CALCUL true RALPH LAUREN CENTER FOR CANCER & PREVENTION 1919 MADISON AVENUE New York NY 10035 020597827 501(C)(3) 1000000 SUPPORT OPERATIONS 1 0 STIPENDS 416 24459000 Form 990, Schedule I FOR THE YEAR 2017, THE AMOUNT IS FOR STIPENDS PAID TO 346 RESEARCH FELLOWS AND 70 GRADUATE SCHOOL STUDENTS. EDUCATION AND TRAINING INCLUDES CLASSROOM INSTRUCTION WITH HANDS-ON EXPERIENCE IN BOTH RESEARCH LABORATORIES AND CLINICAL CARE ACTIVITIES. THE AFOREMENTIONED GRANTEES ARE REQUIRED TO BE IN COMPLIANCE WITH ACADEMIC REQUIREMENTS. THIS INCLUDES DIRECT SUPERVISION AND DIRECTION BY PHYSICIANS AND RESEARCH INVESTIGATORS. RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION (RLC) DURING 2017 MSKCC PAID $1,000,000 TO THE RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION TO OFFSET OPERATING EXPENSES. THE BOARD HAS APPROVED RESOLUTIONS TO SUPPORT THE RALPH LAUREN CENTER UP TO $1,000,000 PER YEAR FROM 2017 - 2019. MSKCC REGULARLY MEETS WITH THE RALPH LAUREN CENTER'S BOARD OF DIRECTORS TO DETERMINE IF THEIR SPENDING IS IN CONFORMITY WITH THE RALPH LAUREN CENTER'S MISSION. X X true true X X X X true true false false false false false true true true JOSE BASELGA MD PHD PIC & CHIEF MEDICAL OFFICER 1134595 0 1181700 0 110876 0 206267 0 44549 0 2677987 0 18500 0 MICHAEL P GUTNICK EXECUTIVE VP & CFO 963609 0 1326230 0 62155 0 39600 0 42357 0 2433951 0 18500 0 KATHRYN MARTIN CHIEF OPERATING OFFICER 1292864 0 1490220 0 33596 0 539600 0 45014 0 3401294 0 18500 0 MARK SVENNINGSON SVP FINANCE & CONTROLLER 616148 0 221515 0 33870 0 39600 0 38498 0 949631 0 18500 0 CRAIG B THOMPSON MD PRESIDENT & CEO 1754674 0 2084620 0 39188 0 1276326 0 167650 0 5322458 0 18500 0 KERRY BESSEY SVP & CHIEF HR OFFICER 641133 0 670000 0 71747 0 39600 0 35361 0 1457841 0 18500 0 ERIC M COTTINGTON PHD SVP RESEARCH & TECHNOLOGY MGMT 583998 0 690000 0 73830 0 39600 0 38393 0 1425821 0 18500 0 FREDRICK GROVES EVP & HOSPITAL ADMINISTRATOR 566121 0 503250 0 63120 0 30600 0 1727 0 1164818 0 9250 0 JASON KLEIN SVP-CHIEF INVESTMENT OFFICER 884782 0 778881 0 27824 0 1484999 0 41716 0 3218202 0 18500 0 CAROLYN B LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 380634 0 76862 0 9482 0 27316 0 13157 0 507451 0 5316 0 JORGE LOPEZ EVP GENERAL COUNSEL 862569 0 1050000 0 70331 0 30600 0 40943 0 2054443 0 7952 0 EDWARD MAHONEY SVP FACILITIES MGMT & CONST 547544 0 689150 0 33020 0 39600 0 29508 0 1338822 0 17504 0 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 416612 0 414650 0 11548 0 29435 0 30364 0 902609 0 6875 0 RICHARD K NAUM SVP DEVELOPMENT 454183 0 1200100 0 37434 0 39600 0 38206 0 1769523 0 17199 0 PATRICIA C SKARULIS SVP-CHIEF INFORMATION OFFICER 662698 0 649300 0 18500 0 39600 0 15745 0 1385843 0 18500 0 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 364002 0 100000 0 66161 0 12354 0 23604 0 566121 0 5330 0 MARK BILSKY MD ATTENDING-DEPT OF NEUROSURGERY 1690391 0 1500000 0 19312 0 330600 0 37321 0 3577624 0 9250 0 BERNARD BOCHNER MD ATTENDING-SURGERY 892684 0 1890000 0 59371 0 30600 0 39817 0 2912472 0 9250 0 PHILIP GUTIN MD CHAIR & ATTENDING NEUROSURGERY 2819618 0 0 0 9250 0 30600 0 26889 0 2886357 0 9250 0 HEDVIG HRICAK MD CHAIRMAN ATTENDING-RADIOLOGY 1402730 0 1060000 0 57454 0 30600 0 62969 0 2613753 0 9250 0 ANNE MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 479735 0 1584118 0 59285 0 30600 0 44482 0 2198220 0 9250 0 THOMAS KELLY MD LAB MEMBER, FORM. SKI DIRECTOR 532758 0 0 0 37337 0 39600 0 40736 0 650431 0 18500 0 ROGER PARKER ESQ EVP & GENERAL COUNSEL 0 0 232700 0 2856 0 0 0 0 0 235556 0 2856 0 Supplemental Compensation Information SCHEDULE J, PART I, LINE 1A BUSINESS OR FIRST CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN SIX CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH AND ENTERTAINMENT OF STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J, PART I LINE 4A-INCLUDED IN FORM 990 IS SEVERANCE PAY FOR EDWIN TALIAFERRO, VP INTERNAL AUDIT & COMPLIANCE, OF $220,608. HE TERMINATED IN APRIL 2017. LINE 4B - THE INSTITUTION MAINTAINS A NONQUALIFIED DEFERRED COMPENSATION PLAN WHICH IS USED FOR EMPLOYER CONTRIBUTIONS IN EXCESS OF THOSE ALLOWED BY THE RETIREMENT PLAN. LINE 7 - INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF PRE-DETERMINED GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. THE COMPENSATION COMMITTEE OF THE BOARD AUTHORIZES ALL EXECUTIVE BONUSES AND INCENTIVE PLANS ON AN ANNUAL BASIS. IN ADDITION, AS WELL AS AN OVERALL AUTHORIZATION AND APPROVAL FOR KEY EMPLOYEES AND OTHER MANAGEMENT INCLUDING PROFESSIONAL AND OTHER STAFF BY SETTING THE BONUS POOL IN CONJUNCTION WITH THE INPUT FROM HUMAN RESOURCES. STAFF BONUSES ARE IMPACTED BY ANNUAL MERIT REVIEW PROCESS LINE 8 - AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649903B91 2008-05-13 456109226 SEE PART VI false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649906RK2 2012-02-16 388814944 SEE PART VI false false false C DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 6499063Z7 2013-06-28 80000000 SEE PART VI false false false D DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2016-04-28 110000000 SEE PART VI false false false A 109425000 0 456110736 0 0 0 2928705 0 0 0 453182031 0 2008 true false true true B 7175000 0 389043483 0 9172031 0 2651698 0 0 92720595 284499159 0 2014 false true true true C 34000000 0 80000000 0 0 0 0 0 0 0 80000000 0 2013 true false true true D 4056866 0 110263219 0 0 0 155282 0 0 110032937 75000 0 2017 false false true true A 0 B false false false true false 0.00000 0.00000 0.00000 false false false true C false false false true false 0.00000 0.00000 0.00000 false false false true D false false false true false 0.00000 0.00000 0.00000 false false false true A false false false true false false 0 false 0 false true B false false false true false false 0 false 0 false true C false true false false false false 0 false 0 false true D false true false false false false 0 false 0 false true A true B true C true D true PART I, COLUMN (F) DESCRIPTION OF PURPOSE 2008-I & II SERIES BONDS - CUSIP #649903ZR5 & #649903B91: 2008-I SERIES BONDS CUSIP #649903ZR5 WITH ISSUE PRICE $164,779,275 AND 2008-II SERIES BONDS CUSIP #649903B91 WITH ISSUE PRICE $291,329,951 ARE COMBINED FOR REPORTING PURPOSE UNDER CUSIP #649903B91. BOTH ISSUES WERE USED TO CURRENT REFUND A PORTION OF THE 2002A BONDS ISSUED JANUARY 24, 2002. 2012 & 2012-I SERIES BONDS - CUSIP #649906RK2: 2012 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP AN AMBULATORY FACILITY AND TO ADVANCE REFUND A PORTION OF THE 2003 SERIES BONDS ISSUED MAY 14, 2003. 2013 SERIES BONDS - CUSIP #6499063Z7: 2013 SERIES BONDS WERE USED TO CURRENT REFUND THE 2010 SERIES BONDS ISSUED SEPTEMBER 2, 2010. 2016 SERIES BONDS (DASNY) - CUSIP #000000000 2016 DASNY SERIES BONDS WERE USED TO CONSTRUCT/RENOVATE AND UPGRADE AND EQUIP VARIOUS FACILITIES. 2016 SERIES BONDS (NJEDA) - CUSIP #000000000 2016 SERIES (NJEDA) BONDS WERE USED TO CONSTRUCT AND EQUIP VARIOUS FACILITIES. 2017 SERIES BONDS - CUSIP #000000000: 2017 SERIES BONDS WERE USED TO CURRENT REFUND THE 2015 SERIES BONDS ISSUED JULY 16, 2015 AND CONSTRUCT VARIOUS FACILITIES. PART II LINE 3 - THE AMOUNT OF PROCEEDS ON PART II LINE 3 IS DIFFERENT FROM PART I COLUMN (E) BECAUSE PART II LINE 3 INCLUDES INVESTMENT INCOME AND GAINS/LOSSES. PART III LINE 3(D) - ANY MANAGEMENT CONTRACTS AND RESEARCH AGREEMENTS THAT MAY RESULT IN PRIVATE BUSINESS USE OF BONDS FINANCED PROPERTIES ARE REVIEWED FIRST BY IN-HOUSE STAFF WHO ARE KNOWLEDGEABLE OF AND RESPONSIBLE FOR THE FORM 990. OUTSIDE COUNSEL IS CONSULTED IF QUESTIONS ARISE. PART IV LINE 2 - THE 2008 SERIES BONDS REBATE CALCULATIONS WERE LAST PERFORMED ON MAY 12, 2013. THE 2012 SERIES BONDS REBATE CALCULATIONS WERE LAST PERFORMED ON FEBRUARY 16, 2017. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2016-09-09 145000000 SEE PART VI false false false B NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY 222045817 000000000 2017-12-20 335567386 SEE PART VI false false false A 18125000 0 145000000 0 0 0 72861 0 0 144627139 300000 0 2017 false false true true B 0 0 335567386 0 0 0 2262236 0 0 86946519 91432989 154925642 true false false true A false false false true false 0.00000 0.00000 0.00000 false false false true B false false false true false 0.00000 0.00000 0.00000 false false false true A false true false false false false 0 false 0 false true B false true false false false false 0 false 0 false true A true B true 0 MS T LINDSTEN SEE PART V 211950 FAMILY EMPLOYMENT false MR I GUTNICK SEE PART V 105088 FAMILY EMPLOYMENT false KING STREET CAPITAL MANAGEMENT SEE PART V 1275616 INVESTMENT MANAGEMENT FEES false JOSE BASELGA MD PHD SEE PART V 96786 MMPC false BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS 1. DR. THOMPSON IS THE PRESIDENT OF THE INSTITUTE. HIS SPOUSE IS A LABORATORY MEMBER FOR SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH. HER COMPENSATION FOR 2017 WAS $211,950. 2. MR. MICHAEL P. GUTNICK IS THE EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER. HIS SON IS A FUND COORDINATOR IN THE DIVISION OF MEDICINE IN THE HOSPITAL. HIS SON'S TOTAL COMPENSATION FOR 2017 WAS $105,088. 3. MS. JAMIE NICHOLLS IS A BOARD MEMBER OF THE INSTITUTION. HER SPOUSE IS A CO-FOUNDER OF KING STREET CAPITAL MANAGEMENT. DURING 2017, THE CENTER PAID KING STREET $733,235 IN MANAGEMENT FEES. THE INVESTMENT AGREEMENT CALLS FOR CARRIED INTEREST INCOME THAT IS NORMAL AND CUSTOMARY IN THE COURSE OF INVESTING IN ALTERNATIVE INVESTMENTS. DURING 2017, CARRIED INTEREST INCOME EARNED WAS $542,381. The Institution invested in King Street prior to Ms. Nicholls joining the Board of Memorial Sloan Kettering Cancer Center. 4. JOSE BASELGA MD PHD IS THE PHYSICIAN IN CHIEF AND CHIEF MEDICAL OFFICER OF THE ORGANIZATION. HE IS ALSO 100% OWNER OF MEMORIAL MEDICAL CARE PC. MEMORIAL MEDICAL CARE PC WAS ESTABLISHED AS A 501 (C)(3) TO PROVIDE HOME HEALTHCARE TO THE HOSPITAL'S BONE MARROW TRANSPLANT PATIENTS. THE PC AND THE HOSPITAL HAVE A MANAGEMENT AGREEMENT WHERE THERE IS NO COST TO THE HOSPITAL FOR THE SERVICE. THE HOSPITAL PROVIDES AND CHARGES THE PC FOR LEASED EMPLOYEES AND MEDICAL SERVICES AS NEEDED. PATIENTS ENROLLED IN THIS PROGRAM ARE BILLED ACCORDINGLY. THE AMOUNT REPORTED IS THE COST OF SUCH SERVICES PROVIDED TO THE PC. THE INDIVIDUALS LISTED WERE NOT A PARTY TO THE TRANSACTIONS. THERE IS NO SHARING OF THE INSTITUTION'S REVENUE. THE PURCHASES OF GOODS OR SERVICES BY THE INSTITUTION WERE MADE IN THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS, AT COMMERCIALLY AVAILABLE RATES NORMALLY CHARGED TO REGULAR CUSTOMERS. X 444 3950387 MARKET VALUE false true false PART I EXCLUDED FROM THIS VALUE ARE PLEDGE PAYMENTS, MADE BY STOCK, TOTALING $7,628,725. PROMISES TO GIVE ARE REPORTED AT THE DATE THE INTENT IS MADE IN WRITING. PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. PART VI, LINES 6-7 THE ARTICLES OF INCORPORATION AND BY-LAWS WERE REVIEWED TO DETERMINE THAT THE SUPPORTED ORGANIZATIONS OUTLINED IN SCHEDULE-A HAVE THE POWER TO ELECT OR APPOINT MEMBERS TO THE BOARD OF THE SUPPORTING ORGANIZATIONS. MEMORIAL SLOAN-KETTERING CANCER CENTER, EIN 13-1924236, (MSK), IS THE SINGLE MEMBER OF THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM LLC, PCCTC, WHO HAS ELECTED TO BE TREATED AS A DISREGARDED ENTITY OF MSK FOR TAX PURPOSES AND MSKCC PROTON, INC. WHO HAS ELECTED TO BE TREATED AS A CORPORATION FOR TAX PURPOSES. MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES EIN 13-1624082, (MEM), IS THE SINGLE MEMBER OF MSKCC PROPERTIES LLC, WHO HAS ELECTED TO BE TREATED AS A CORPORATION FOR TAX PURPOSES. PART VI, LINE 11B PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE SR. VP OF FINANCE AND THE CHIEF FINANCIAL OFFICER. IT IS THEN PRESENTED TO AND REVIEWED BY THE JOINT AUDIT COMMITTEE OF THE BOARD. THE JOINT AUDIT COMMITTEE REFERS THE FORM 990 TO THE FULL BOARD, AND A COPY IS PROVIDED TO EACH BOARD MEMBER FOR FURTHER REVIEW. MEMORIAL SLOAN-KETTERING'S FORM 990 IS REVIEWED BY OUTSIDE COUNSEL AND IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. PART VI, LINE 12C THE COMPLIANCE OFFICER AND STAFF ARE RESPONSIBLE FOR ADMINISTERING THE CONFLICT OF INTEREST PROGRAM--INCLUDING THE IMPLEMENTATION OF THE POLICY--BY MAINTAINING PROCESSES FOR DISCLOSURE OF OUTSIDE ACTIVITIES AND FOR THE TIMELY REVIEW OF REPORTED INTERESTS, INCLUDING: 1. MANAGEMENT OF THE ANNUAL DISCLOSURE CERTIFICATION PROCESS AND THE PROCESS BY WHICH COVERED PERSONS DISCLOSE AT TIME OF HIRE. COVERED PERSONS RECEIVE AN ANNUAL QUESTIONNAIRE REQUESTING DISCLOSURE OF RELATIONSHIPS AND TRANSACTIONS THAT MIGHT INVOLVE A CONFLICT OF INTEREST. QUESTIONNAIRE RESPONSES ARE REVIEWED BY THE COMPLIANCE OFFICER AND STAFF. FOLLOW-UP INQUIRIES ARE MADE IF NEEDED. MATTERS ARE SUBMITTED TO AN INTERNAL MANAGEMENT COMMITTEE AND A COMMITTEE OF THE BOARD OF MANAGERS IF ADJUDICATION IS NEEDED. 2. REVIEW AND ADJUDICATION OF OUTSIDE ACTIVITIES THAT REQUIRE PRE- APPROVAL OR DISCLOSURE; FACILITATION OF A REVIEW BY THE OFFICE OF INDUSTRIAL AFFAIRS OF ANY OUTSIDE ACTIVITIES THAT INVOLVE INTELLECTUAL PROPERTY OR OTHERWISE INVOLVE AN ACTIVITY IN WHICH THE CENTER'S RIGHTS MAY REQUIRE PROTECTION. 3. ADMINISTRATION OF CONFLICT OF INTEREST ADVISORY COMMITTEE MEETINGS, INCLUDING DEVELOPMENT AND DISTRIBUTION OF AGENDAS AND SUPPORTING DOCUMENTS, DRAFTING AND DISTRIBUTION OF MINUTES, AND MAINTENANCE OF COMMITTEE RECORDS. 4.DOCUMENTATION OF THE OUTCOME OF ALL REVIEWS OF REPORTED OUTSIDE ACTIVITIES. COMMUNICATION TO THE COVERED PERSON OF THE OUTCOME OF ALL REVIEWS, INCLUDING DOCUMENTATION OF MANAGEMENT PLANS. AS PART OF THE CLINICAL RESEARCH REVIEW PROCESS, QUESTIONS ON THE PROTOCOL SUBMISSION FORM ARE DESIGNED TO ELICIT INFORMATION ABOUT POTENTIAL CONFLICTS. SITUATIONS IN WHICH A STAFF PARTICIPANT IN RESEARCH REPORTS A POTENTIAL CONFLICT ARE REFERRED TO THE CHAIR OF THE COIAC AND TO THE COMPLIANCE OFFICER FOR REVIEW. THE BOARD OF MEMORIAL SLOAN-KETTERING CANCER CENTER HAS MEMBERS THAT ACTIVELY SERVE AS OFFICERS AND/OR BOARD MEMBERS OF PUBLICLY-TRADED COMPANIES. THE INSTITUTION MAY PROCURE GOODS AND/OR SERVICES FROM THESE PUBLICLY TRADED COMPANIES THROUGH THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS ON TERMS AND CONDITIONS WHICH ARE THE SAME THAT SUCH COMPANIES CHARGE TO THE GENERAL PUBLIC. ANY OF OUR BOARD MEMBERS THAT HAVE AN AFFILIATION WITH SUCH COMPANIES ARE NOT INVOLVED IN THE TRANSACTION, INCLUDING, WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, IN NEGOTIATING OR AFFECTING THE TERMS OF THE TRANSACTION. THE INSTITUTION HAS A COMPREHENSIVE CONFLICT OF INTEREST POLICY. REPORTABLE TRANSACTIONS IDENTIFIED THROUGH OUR ANNUAL CONFLICT OF INTEREST QUESTIONNAIRE ARE DISCLOSED ON SCHEDULE L. THESE TRANSACTIONS WERE ALSO CONSUMMATED ON AN ARM'S LENGTH BASIS BY MANAGEMENT OF THE INSTITUTION. MSKCC'S "POLICY ON CONFLICTS OF INTERESTS FOR DIRECTORS AND KEY EMPLOYEES" APPLIES TO ANY BOARD OF MANAGERS MEMBER, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD-DELEGATED POWERS. INDIVIDUALS COVERED BY THIS POLICY HAVE A DUTY TO DISCLOSE FINANCIAL INTERESTS, AS DEFINED BY THE POLICY, ANNUALLY AND AS THEY ARISE. IN THE EVENT A COVERED INDIVIDUAL IS INVOLVED IN A BOARD OR COMMITTEE ACTION (SUCH AS APPROVAL OF A TRANSACTION OR ARRANGEMENT) AND THE INDIVIDUAL HAS A FINANCIAL INTEREST RELATED TO THE MATTER BEFORE THE BOARD, THE INDIVIDUAL MUST DISCLOSE THE FINANCIAL INTEREST AND ALL MATERIAL FACTS TO THE BOARD OR COMMITTEE. THE INDIVIDUAL MUST LEAVE THE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON, AND THE REMAINING, DISINTERESTED BOARD OR COMMITTEE MEMBERS ARE RESPONSIBLE TO DECIDE IF A CONFLICT EXISTS. IF A DETERMINATION IS MADE THAT A CONFLICT EXISTS, THE INVOLVED INDIVIDUAL MAY MAKE A PRESENTATION TO THE BOARD OR COMMITTEE BUT S/HE MUST LEAVE THE MEETING DURING THE DISCUSSION OF AND THE VOTE ON THE TRANSACTION OR ARRANGEMENT. THE BOARD OR COMMITTEE IS REQUIRED TO DETERMINE WHETHER MSKCC CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS FROM AN UNCONFLICTED PERSON OR ENTITY. AS APPROPRIATE, THE CHAIRPERSON OF THE BOARD OR COMMITTEE IS RESPONSIBLE TO APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. BOARD OR COMMITTEE IS REQUIRED TO DETERMINE WHETHER MSKCC CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS FROM AN UNCONFLICTED PERSON OR ENTITY. S/HE MUST LEAVE THE MEETING DURING THE DISCUSSION OF AND THE VOTE ON THE TRANSACTION OR ARRANGEMENT. IN JANUARY 2018, A PERIOD NOT COVERED BY THIS RETURN, AND NOT BEFORE THEN, THE ORGANIZATION INVESTED IN A PRIVATE COMPANY IN WHICH CERTAIN OF THE ORGANIZATION'S DIRECTORS AND EMPLOYEES HAD ALSO INVESTED. TO THE EXTENT THAT THIS TRANSACTION IS REPORTABLE ON SCHEDULE L OF FORM 990 FOR THE FILING YEAR IN WHICH THE INVESTMENT OCCURRED, THE ORGANIZATION WILL APPROPRIATELY DISCLOSE THE TRANSACTION AND ALL THE PERTINENT INFORMATION REQUIRED BY SCHEDULE L. PART VI, LINE 15 MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC) IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE MSKCC BOARD OF OVERSEERS AND MANAGERS HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED ENTIRELY OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARDS TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS DECEMBER 2016. THIS REVIEW SETS THE COMPENSATION FOR THE FOLLOWING YEAR. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC, AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. ON AN ANNUAL BASIS, THE COMMITTEE PROVIDES THE FULL BOARD WITH AN OVERVIEW OF ITS DETERMINATIONS AND PROCESS. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. - THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. PART VI, LINE 19 OUR AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS CAN BE ACCESSED AT THE FOLLOWING WEB ADDRESS: WWW.DACBOND.COM. THE INSTITUTION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. THE INFORMATION AVAILABLE ON THIS WEB SITE INCLUDES AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS AND THE BOND OFFERING STATEMENTS FOR ALL OUR DEBT ISSUES. IN ADDITION, COPIES OF THE GROUP 990 AND FILED 990T ARE ALSO AVAILABLE. THE CONFLICT OF INTEREST POLICY IS AVAILABLE TO THE PUBLIC UPON REQUEST AND IT ALSO CAN BE FOUND AT THE FOLLOWING INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT MADE AVAILABLE TO THE PUBLIC. PART VII, SECTION A THIS IRS FORM 990 IS FILED UNDER GROUP EXEMPTION NUMBER 3475, EIN 91-2154267. THE ATTACHED LIST REPRESENTS MEMBERS FROM THE GOVERNING BOARDS OF THE FOLLOWING AFFILIATED INSTITUTIONS THAT MAKE UP OUR EXEMPT GROUP: MEMORIAL SLOAN-KETTERING CANCER CENTER (MSK) EIN 13-1924236, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (MEM) EIN 13-1624082, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (SKI) EIN 13-1624182, S.K.I. REALTY, INC. (SKR) EIN 13-3389586, LOUIS V. GERSTNER JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES (SKG) EIN 20-2212588, MSK INSURANCE US, INC. (MVI) EIN 83-0363317, AND MSKCC PROTON INC.,(MPI) EIN 35-2397819. ALSO INCLUDED IN THE GROUP IS MSK PROPERTIES LLC. EIN 35-2464610 WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER. MEMORIAL SLOAN KETTERING CANCER CENTER BOARD OF MANAGERS RICHARD I. BEATTIE IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR. JONATHAN N. GRAYER JAMIE GREGORY, EFFECTIVE JUNE 2017 BENJAMIN W. HEINEMAN, JR. DAVID H. KOCH MARIE-JOSEE KRAVIS, VICE CHAIR OF THE BOARD JAMIE C. NICHOLLS, NOT INDEPENDENT SEE SCHEDULE L JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS, BOARD MEMBER & TREASURER ALEXANDER T. ROBERTSON JAMES D. ROBINSON III, BOARD MEMBER & HONORARY CHAIRMAN OF THE BOARD VIRGINIA M. ROMETTY NORMAN C SELBY, BOARD MEMBER & SECRETARY STEPHEN C. SHERRILL LAVINIA BRANCA SNYDER, UNTIL JUNE 2017 PETER J. SOLOMON JOHN R. STRANGFELD SCOTT M. STUART, VICE CHAIR OF THE BOARD CRAIG B. THOMPSON, M.D., BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE OFFICER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III, CHAIRMAN OF THE BOARD PETER A. WEINBERG DEBORAH C. WRIGHT 31 TOTAL BOARD MEMBERS 29 INDEPENDENT BOARD MEMBERS MEMORIAL HOSPITAL BOARD OF MANAGERS RICHARD I. BEATTIE, HONORARY CHAIRMAN OF THE BOARD IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR. JONATHAN N. GRAYER JAMEE Gregory, EFFECTIVE JUNE 2017 BENJAMIN W. HEINEMAN, JR., VICE CHAIR OF THE BOARD DAVID H. KOCH MARIE-JOSEE KRAVIS JAMIE C. NICHOLLS JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS, BOARD MEMBER & TREASURER ALEXANDER T. ROBERTSON JAMES D. ROBINSON III VIRGINIA M. ROMETTY NORMAN C SELBY, BOARD MEMBER & SECRETARY STEPHEN C. SHERRILL LAVINIA BRANCA, UNTIL JUNE 2017 SNYDER PETER J. SOLOMON JOHN R. STRANGFELD SCOTT M. STUART, CHAIRMAN OF THE BOARD CRAIG B. THOMPSON, M.D., BOARD MEMBER, CHIEF EXECUTIVE OFFICER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III PETER A. WEINBERG DEBORAH C. WRIGHT 31 TOTAL BOARD MEMBERS 30 INDEPENDENT BOARD MEMBERS SLOAN KETTERING INSTITUTE BOARD OF MANAGERS RICHARD I. BEATTIE IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR., HONORARY CHAIRMAN OF THE BOARD JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. JAMEE GREGORY, EFFECTIVE JUNE 2017 DAVID H. KOCH MARIE-JOSEE KRAVIS JAMIE C. NICHOLLS JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS, BOARD MEMBER & TREASURER ALEXANDER T. ROBERTSON JAMES D. ROBINSON III VIRGINIA M. ROMETTY NORMAN C SELBY, BOARD MEMBER & SECRETARY LAVINIA BRANCA SNYDER, UNTIL JUNE 2017 STEPHEN C. SHERRILL PETER J. SOLOMON JOHN R. STRANGFELD SCOTT M. STUART CRAIG B. THOMPSON, M.D., BOARD MEMBER, CHIEF EXECUTIVE OFFICER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III DEBORAH C. WRIGHT 30 TOTAL BOARD MEMBERS 29 INDEPENDENT BOARD MEMBERS S.K.I. REALTY BOARD OF MANAGERS RICHARD I. BEATTIE LOUIS V. GERSTNER, JR. JAMES G. NIVEN, PRESIDENT CLIFTON S. ROBBINS SCOTT M. STUART DOUGLAS A. WARNER III, CHAIRMAN OF THE BOARD 6 TOTAL BOARD MEMBERS 6 INDEPENDENT BOARD MEMBERS GERSTNER GRADUATE SCHOOL BOARD OF MANAGERS RICHARD I. BEATTIE ELLEN V. FUTTER LOUIS V. GERSTNER, JR., CHAIRMAN OF THE BOARD DAVID H. KOCH MARIE-JOSEE KRAVIS PETER J SOLOMON CRAIG B. THOMPSON, M.D. BOARD MEMBER, PRESIDENT, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III 8 TOTAL BOARD MEMBERS 7 INDEPENDENT BOARD MEMBERS MSK INSURANCE U.S. BAORD OF MANAGERS KATHRYN MARTIN, DIRECTOR AND SECRETARY, EMPLOYEE NOT AN INDEPENDENT BOARD MEMBER STEPHEN C. SHERRILL, CHAIRMAN OF THE BOARD MARK SVENNINGSON, BOARD MEMBER AND PRESIDENT EMPLOYEE, NOT INDEPENDENT BOARD MEMBER JEFFREY P. JOHNSON, BOARD MEMBER AND VICE PRESIDENT MICHAEL P. GUTNICK, BOARD MEMBER AND TREASURER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER 5 TOTAL BOARD MEMBERS 2 INDEPENDENT BOARD MEMBERS MSKCC PROTON INC., BOARD OF DIRECTORS JOSE BASELGA MD PHD, EMPLOYEE NOT AN INDEPENDENT DIRECTOR MICHAEL P GUTNICK, EMPLOYEE NOT AN INDEPENDENT DIRECTOR 2 TOTAL DIRECTORS, 0 INDEPENDENT DIRECTORS PART VII, SECTION B AMOUNTS PAID TO INDEPENDENT CONTRACTORS INCLUDE AMOUNTS PAID TO SUBCONTRACTORS AS WELL AS REIMBURSABLE EXPENSES. PART XI RECONCILIATION OF NET ASSETS, OTHER NON-OPERATING (EXPENSE): CHANGE IN POSTRETIREMENT $(120,481,000) PENSION SETTLEMENT ( 33,480,000) OTHER NON OPERATING EXPENSE NET OF RECLASSIFICATIONS ( 34,902,199) TOTAL $(188,863,199) PROSTATE CANCER CLINICAL TRIALS 1275 YORK AVE NEW YORK NY 10065 352506225 CANCER CARE DE 12324000 4938000 MSKCC RALPH LAUREN CTR FOR CANCER & PREVENTION 1919 MADISON AVE NEW YORK NY 10036 020597827 CANCER CARE NY 501( C)3 10 MSKCC true MEMORIAL MEDICAL CARE PC 1275 YORK AVENUE NEW YORK NY 10065 352491455 CANCER CARE NY 501( C)3 10 MSKCC true MEM CRITICAL CARE 1275 YORK AVE NY NY 10065 133348785 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM INFECT DISEASE 1275 YORK AVE NY NY 10065 133278582 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM MEDICAL CONSULT 1275 YORK AVE NY NY 10065 133278550 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NUTRITION GRP 1275 YORK AVE NY NY 10065 133278576 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM SOLID TUMOR GRP 1275 YORK AVE NY NY 10065 133278578 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PULMONARY FUNC 1275 YORK AVE NY NY 10065 133304834 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CARDIOPULMONARY 1275 YORK AVE NY NY 10065 133278552 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK RADIOLOGY GRP 1275 YORK AVE NY NY 10065 133375559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NUCLEAR MED 1275 YORK AVE NY NY 10065 133278580 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM RADIATION ONCOL 1275 YORK AVE NY NY 10065 133237927 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PATHOLOGY GRP 1275 YORK AVE NY NY 10065 133365998 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ANESTHESIOLOGY 1275 YORK AVE NY NY 10065 133367135 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PEDIATRICS GRP 1275 YORK AVE NY NY 10065 133346908 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROLOGY GRP 1275 YORK AVE NY NY 10065 133399377 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PSYCHIATRY GRP 1275 YORK AVE NY NY 10065 133430629 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK AT GUTTMAN 1275 YORK AVE NY NY 10065 133875002 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK PHYS AT PHELPS 1275 YORK AVE NY NY 10065 133897156 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK AT MERCY 1275 YORK AVE NY NY 10065 133954858 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK PHYS-ST CLARE'S 1275 YORK AVE NY NY 10065 133897154 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK REHABILITATION 1275 YORK AVE NY NY 10065 134010371 HEALTH CARE NY MEM REALATED 0 0 false 0 true 1.00000 MSK SURGERY GROUP 1275 YORK AVE NY NY 10065 134010372 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK HAUPPAUGE 1275 YORK AVE NY NY 10065 134059247 HEALTH CARE NY MEM related 0 0 false 0 true 1.00000 MEM NEUROSURGERY 1275 YORK AVE NY NY 10065 133251621 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 INTERGRATIVE MED 1275 YORK AVE NY NY 10065 542092060 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK-REGIONAL NETWK 1275 YORK AVE NY NY 10065 020594889 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK BASKING RIDGE 1275 YORK AVE NY NY 10065 593801080 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM URGENT CARE GRP 1275 YORK AVE NY NY 10065 651263291 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLN GENETICS 1275 YORK AVE NY NY 10065 651263292 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DEVELOP CHEMO 1275 YORK AVE NY NY 10065 133278548 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK CLINIC PRACTICE 1275 YORK AVE NY NY 10065 510616510 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM BREAST GROUP 1275 YORK AVE NY NY 10065 562568640 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM COLORECTAL GRP 1275 YORK AVE NY NY 10065 562568642 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DENTAL GRP 1275 YORK AVE NY NY 10065 562568630 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLINICAL IMMUNO 1275 YORK AVE NY NY 10065 133278559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM GASTRIC MIX TMR 1275 YORK AVE NY NY 10065 562568650 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM GYNECOLOGY GRP 1275 YORK AVE NY NY 10065 562568655 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEAD & NECK GRP 1275 YORK AVE NY NY 10065 562568656 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEPATOBILIARY 1275 YORK AVE NY NY 10065 562568667 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROSURGERY 1275 YORK AVE NY NY 10065 562568663 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPT ABRAMSON 1275 YORK AVE NY NY 10065 562568627 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPTHALMIC ONOCO 1275 YORK AVE NY NY 10065 562568675 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPHTHALMOLOGY 1275 YORK AVE NY NY 10065 562568669 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ORTHOPEDIC GRP 1275 YORK AVE NY NY 10065 562568680 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PEDIATRIC SURG 1275 YORK AVE NY NY 10065 562568683 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLINICAL PHY 1275 YORK AVE NY NY 10065 133278556 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PLASTIC RECON 1275 YORK AVE NY NY 10065 562568623 HEALTH CARE NY MEM RELATD 0 0 false 0 true 1.00000 MEM THORACIC GRP 1275 YORK AVE NY NY 10065 562568677 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM UROLOGY GRP 1275 YORK AVE NY NY 10065 562568638 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PAIN SERVICE 1275 YORK AVE NY NY 10065 651283822 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DERMATOLOGY GRP 1275 YORK AVE NY NY 10065 133278581 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ENDOCRINE GRP 1275 YORK AVE NY NY 10065 133278583 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 GASTROENTEROLOGY 1275 YORK AVE NY NY 10065 133278574 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEMATOLOGYLYMP 1275 YORK AVE NY NY 10065 133278575 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 BTS LIQUIDATING 1430 BROADWAY NY NY 10018 262602952 INVESTMENT MSK EXCLUDED UNDER 512 6500115 79326518 false 0 true 0.80000 CHARITABLE REMAINDER TRUSTS 174 N/A TWO SIGMA US ALL CAP 89 NEXUS WAY CAMANA BAY GRAND CAYMAN CJ KY1-9007 INVESTMENT CJ MSK C 16352833 108743933 1.00000 true NEWMARKET AFRICA 89 NEXUS WAY CAMANA BAY GRAND CAYMAN CJ KY1-9007 INVESTMENT CJ MSK C 151508 427052 0.05400 false false true false false false false false false true true true true false false false true false false RALPH LAUREN CTR FOR CANCER & PREVENTION Q 2760849 COST RALPH LAUREN CTR FOR CANCER & PREVENTION B 1000000 COST MEMORIAL MEDICAL CARE PC Q 96786 COST